OraSure Technologies, Inc.
HealthcareNASDAQ:OSUR · NASDAQ Global Select
-$0.01 today
Vol 0.49M · Avg 0.61M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$113.0M of revenue converted into -$75.1M of net income for the selected period. Gross margin is 41.0% and net margin is -66.5%, showing how much revenue survives after costs and taxes. EPS is $-1.04, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $115.0M -38.1% | $185.8M -54.2% | $405.5M +4.6% | $387.5M +65.8% | $233.7M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $66.8M -39.0% | $109.6M -51.5% | $226.1M -5.4% | $239.0M +105.9% | $116.1M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $48.2M -36.8% | $76.2M -57.5% | $179.4M +20.9% | $148.4M +26.2% | $117.6M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 41.9% +0.9pp | 41.0% -3.2pp | 44.2% +5.9pp | 38.3% -12.0pp | 50.3% | 9.8% | 28.9% | 38.3% |
| Research & Development | $42.5M +74.2% | $24.4M -26.4% | $33.2M -8.5% | $36.2M +6.0% | $34.2M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $73.8M +1.9% | $72.4M -21.5% | $92.2M -21.5% | $117.4M +23.5% | $95.1M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $116.3M +20.1% | $96.8M -22.7% | $125.3M -18.4% | $153.7M +18.9% | $129.2M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $10.0M -8.3% | $10.9M -45.4% | $19.9M +42.1% | $14.0M +20.1% | $11.7M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$57.0M -734.1% | -$6.8M -109.0% | $76.2M +4646.7% | -$1.7M -170.8% | $2.4M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -49.5% -45.8pp | -3.7% -22.5pp | 18.8% +19.2pp | -0.4% -1.4pp | 1.0% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$68.1M -230.7% | -$20.6M -138.1% | $54.1M +1131.5% | -$5.2M +55.0% | -$11.6M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -59.2% -48.1pp | -11.1% -24.4pp | 13.3% +14.7pp | -1.4% +3.6pp | -5.0% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $1.2M -58.8% | $2.9M +33.0% | $2.2M +120.9% | -$10.4M -542.6% | $2.4M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$66.9M -278.1% | -$17.7M -131.5% | $56.3M +458.9% | -$15.7M -68.7% | -$9.3M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -58.2% -48.7pp | -9.5% -23.4pp | 13.9% +17.9pp | -4.0% -0.1pp | -4.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $1.8M +0.1% | $1.8M -30.9% | $2.6M +78.5% | $1.5M -89.4% | $13.7M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$68.7M -252.5% | -$19.5M -136.3% | $53.7M +413.2% | -$17.1M +25.5% | -$23.0M | $4.9B | $4.8B | $4.7B |
| Net Margin | -59.8% -49.3pp | -10.5% -23.7pp | 13.2% +17.7pp | -4.4% +5.4pp | -9.8% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$1 -261.5% | -$0 -135.6% | $1 +392.0% | -$0 +21.9% | -$0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$1 -261.5% | -$0 -136.1% | $1 +388.0% | -$0 +21.9% | -$0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $73.5M -1.3% | $74.4M +1.5% | $73.3M +1.2% | $72.5M +0.7% | $72.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $73.5M -1.3% | $74.4M +0.1% | $74.4M +2.6% | $72.5M +0.7% | $72.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Genfit S.A.
GNFT
$445.68M
Prenetics Global Limited
NASDAQ:PRE
$367.72M
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$284.66M
Perspective Therapeutics, Inc.
AMEX:CATX
$227.89M
Utah Medical Products, Inc.
NASDAQ:UTMD
$216.00M
Profound Medical Corp.
NASDAQ:PROF
$200.47M
Protara Therapeutics, Inc.
NASDAQ:TARA
$150.50M
Neonc Technologies Holdings, Inc.
NASDAQ:NTHI
$94.98M
Neuronetics, Inc.
NASDAQ:STIM
$92.55M
Nyxoah S.A.
NASDAQ:NYXH
$55.05M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does OSUR generate?
OraSure Technologies, Inc. (OSUR) reported $115.02M of revenue in fiscal 2025.
Is OSUR profitable?
OraSure Technologies, Inc. (OSUR) reported -$68,731,000.00 of net income, with a net margin of -59.8%.
Explore More
Continue the stock analysis
Jump to another research area for this company.